Fibroblast growth factor-23 but not sKlotho levels are related to diastolic dysfunction in type 1 diabetic patients with early diabetic nephropathy

DOĞAN, BURCU; ARIKAN, İZZET; Guler, Derya; KELES, Nursen; ISBILEN, Banu; Isman, Ferruh; OĞUZ, AYTEKİN

doi:10.1007/s11255-015-1190-y

Fibroblast growth factor-23 but not sKlotho levels are related to diastolic dysfunction in type 1 diabetic patients with early diabetic nephropathy

DOĞAN B., ARIKAN İ. H. , Guler D., KELES N., ISBILEN B., Isman F., ...More

INTERNATIONAL UROLOGY AND NEPHROLOGY, vol.48, no.3, pp.399-407, 2016 (Journal Indexed in SCI)

Publication Type: Article / Article
Volume: 48 Issue: 3
Publication Date: 2016
Doi Number: 10.1007/s11255-015-1190-y
Title of Journal : INTERNATIONAL UROLOGY AND NEPHROLOGY
Page Numbers: pp.399-407
Keywords: Type 1 diabetes mellitus, sKlotho, FGF-23, Cardiac function, Diabetic nephropathy, CHRONIC KIDNEY-DISEASE, LEFT-VENTRICULAR HYPERTROPHY, SOLUBLE SERUM KLOTHO, HEART-FAILURE, CARDIOVASCULAR-DISEASE, VASCULAR DYSFUNCTION, FGF-23, MORTALITY, PHOSPHATE, COMMUNITY

Abstract

To investigate the soluble Klotho (sKlotho) and fibroblast growth factor-23 (FGF-23) levels and echocardiographic findings in type 1 diabetic patients with no or early diabetic nephropathy.